 Product development was focused on therapeutics for gastrointestinal, cardiovascular and respiratory disorders and pain control.At the time of the fusion, Astra was the largest Swedish pharmaceutical company.Astra also operated Astra Tech, a medical devices company, and marketed pharmaceuticals outside their primary development area, including anti-infective agents.